Royal Bank of Canada Buys 24,081 Shares of U.S. Physical Therapy, Inc. $USPH

Royal Bank of Canada raised its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 133,777 shares of the company’s stock after buying an additional 24,081 shares during the quarter. Royal Bank of Canada’s holdings in U.S. Physical Therapy were worth $10,029,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of U.S. Physical Therapy by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 1,085,336 shares of the company’s stock worth $84,754,000 after purchasing an additional 15,712 shares in the last quarter. Copeland Capital Management LLC raised its stake in U.S. Physical Therapy by 6.5% during the 1st quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock worth $62,729,000 after buying an additional 50,717 shares during the period. Dimensional Fund Advisors LP raised its stake in U.S. Physical Therapy by 3.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company’s stock worth $38,035,000 after buying an additional 15,668 shares during the period. William Blair Investment Management LLC lifted its holdings in U.S. Physical Therapy by 7.2% during the fourth quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock worth $28,949,000 after acquiring an additional 24,848 shares in the last quarter. Finally, Schroder Investment Management Group lifted its holdings in U.S. Physical Therapy by 45.9% during the fourth quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after acquiring an additional 114,618 shares in the last quarter.

U.S. Physical Therapy Price Performance

USPH stock opened at $79.89 on Monday. The stock has a 50-day moving average price of $70.17 and a two-hundred day moving average price of $74.15. The stock has a market cap of $1.22 billion, a PE ratio of 469.97, a price-to-earnings-growth ratio of 2.18 and a beta of 1.13. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.48. U.S. Physical Therapy, Inc. has a 1 year low of $58.19 and a 1 year high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.06). The firm had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.81 EPS. Equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.98 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a $0.46 dividend. The ex-dividend date is Friday, August 21st. This represents a $1.84 annualized dividend and a yield of 2.3%. U.S. Physical Therapy’s payout ratio is presently 1,082.35%.

Insider Buying and Selling

In other news, Director Peter Francis Minan bought 492 shares of the business’s stock in a transaction on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the purchase, the director owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on USPH shares. Barrington Research lowered their price target on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. Citizens Jmp reiterated a “market outperform” rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Friday, July 24th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.